Skip to main content
NCBI home page
American Journal of Public Health logoLink to American Journal of Public Health
. 1999 Jun;89(6):938–944. doi: 10.2105/ajph.89.6.938

Great expectations: historical perspectives on genetic breast cancer testing.

B H Lerner 1
PMCID: PMC1508642  PMID: 10358693

Abstract

Women who test positive for a genetic breast cancer marker may have more than a 50% chance of developing the disease. Although past screening technologies have sought to identify actual breast cancers, as opposed to predisposition, the history of screening may help predict the societal response to genetic testing. For decades, educational messages have encouraged women to find breast cancers as early as possible. Such messages have fostered the popular assumption that immediately discovered and treated breast cancers are necessarily more curable. Research, however, has shown that screening improves the prognosis of some--but not all--breast cancers, and also that it may lead to unnecessary interventions. The dichotomy between the advertised value of early detection and its actual utility has caused particular controversy in the United States, where the cultural climate emphasizes the importance of obtaining all possible medical information and acting on it. Early detection has probably helped to lower overall breast cancer mortality. But it has proven hard to praise aggressive screening without exaggerating its merits. Women considering genetic breast cancer testing should weight the benefits and limitations of early knowledge.

Full text

PDF
938

Images in this article

939FIGURE 1
on p.939

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANGLEM T. J., GRAY E. B., Jr Cancer of the breast and biological predeterminism: a re-evaluation. Cancer. 1961 Sep-Oct;14:1122–1126. doi: 10.1002/1097-0142(196109/10)14:5<1122::aid-cncr2820140533>3.0.co;2-6. [DOI] [PubMed] [Google Scholar]
  2. ATKINS H. J. B. Carcinoma of the breast. Br Med J. 1953 May 16;1(4819):1099–1102. doi: 10.1136/bmj.1.4819.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. BLACK M. M., SPEER F. D. Biologic variability of breast carcinoma in relation to diagnosis and therapy. N Y State J Med. 1953 Jul 1;53(13):1560–1563. [PubMed] [Google Scholar]
  4. BLOOM H. J. G. Further studies on prognosis of breast carcinoma. Br J Cancer. 1950 Dec;4(4):347–367. doi: 10.1038/bjc.1950.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Black W. C., Welch H. G. Advances in diagnostic imaging and overestimations of disease prevalence and the benefits of therapy. N Engl J Med. 1993 Apr 29;328(17):1237–1243. doi: 10.1056/NEJM199304293281706. [DOI] [PubMed] [Google Scholar]
  6. Boyd D. P. Biological predeterminism. Lahey Clin Found Bull. 1969 Jul-Sep;18(3):135–136. [PubMed] [Google Scholar]
  7. Burke W., Daly M., Garber J., Botkin J., Kahn M. J., Lynch P., McTiernan A., Offit K., Perlman J., Petersen G. Recommendations for follow-up care of individuals with an inherited predisposition to cancer. II. BRCA1 and BRCA2. Cancer Genetics Studies Consortium. JAMA. 1997 Mar 26;277(12):997–1003. [PubMed] [Google Scholar]
  8. COBB B., CLARK R. L., Jr, McGUIRE C., HOWE C. D. Patient-responsible delay of treatment in cancer; a social psychological study. Cancer. 1954 Sep;7(5):920–926. doi: 10.1002/1097-0142(195409)7:5<920::aid-cncr2820070516>3.0.co;2-r. [DOI] [PubMed] [Google Scholar]
  9. Caplan L. S. Patient delay in seeking help for potential breast cancer. Public Health Rev. 1995;23(3):263–274. [PubMed] [Google Scholar]
  10. Durfy S. J., Peters J. A. For the benefit of all. Hastings Cent Rep. 1993 Sep-Oct;23(5):28–30. [PubMed] [Google Scholar]
  11. Ernster V. L. Mammography screening for women aged 40 through 49--a guidelines saga and a clarion call for informed decision making. Am J Public Health. 1997 Jul;87(7):1103–1106. doi: 10.2105/ajph.87.7.1103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Facione N. C. Delay versus help seeking for breast cancer symptoms: a critical review of the literature on patient and provider delay. Soc Sci Med. 1993 Jun;36(12):1521–1534. doi: 10.1016/0277-9536(93)90340-a. [DOI] [PubMed] [Google Scholar]
  13. Feinstein A. R., Spitz H. The epidemiology of cancer therapy. I. Clinical problems of statistical surveys. Arch Intern Med. 1969 Feb;123(2):171–186. [PubMed] [Google Scholar]
  14. Fisher B. The evolution of paradigms for the management of breast cancer: a personal perspective. Cancer Res. 1992 May 1;52(9):2371–2383. [PubMed] [Google Scholar]
  15. Fisher E. R., Redmond C., Fisher B. A perspective concerning the relation of duration of symptoms to treatment failure in patients with breast cancer. Cancer. 1977 Dec;40(6):3160–3167. doi: 10.1002/1097-0142(197712)40:6<3160::aid-cncr2820400661>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  16. Freedman T. G. Genetic susceptibility testing. A therapeutic illusion. Cancer. 1997 Jun 1;79(11):2063–2066. doi: 10.1002/(sici)1097-0142(19970601)79:11<2063::aid-cncr1>3.0.co;2-q. [DOI] [PubMed] [Google Scholar]
  17. GERSHON-COHEN J., BERGER S. M., KLICKSTEIN H. S. ROENTGENOGRAPHY OF BREAST CANCER MODERATING CONCEPT OF "BIOLOGIC PREDETERMINISM". Cancer. 1963 Aug;16:961–964. doi: 10.1002/1097-0142(196308)16:8<961::aid-cncr2820160802>3.0.co;2-b. [DOI] [PubMed] [Google Scholar]
  18. GOLDSEN R. K., GERHARDT P. R., HANDY V. H. Some factors related to patient delay in seeking diagnosis for cancer symptoms. Cancer. 1957 Jan-Feb;10(1):1–7. doi: 10.1002/1097-0142(195701/02)10:1<1::aid-cncr2820100102>3.0.co;2-z. [DOI] [PubMed] [Google Scholar]
  19. Grann V. R., Panageas K. S., Whang W., Antman K. H., Neugut A. I. Decision analysis of prophylactic mastectomy and oophorectomy in BRCA1-positive or BRCA2-positive patients. J Clin Oncol. 1998 Mar;16(3):979–985. doi: 10.1200/JCO.1998.16.3.979. [DOI] [PubMed] [Google Scholar]
  20. Haagensen C. D., Stout A. P. CARCINOMA OF THE BREAST-PART I; RESULTS OF TREATMENT. Ann Surg. 1942 Dec;116(6):801–815. doi: 10.1097/00000658-194212000-00002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Hackett T. P., Cassem N. H., Raker J. W. Patient delay in cancer. N Engl J Med. 1973 Jul 5;289(1):14–20. doi: 10.1056/NEJM197307052890104. [DOI] [PubMed] [Google Scholar]
  22. Healy B. BRCA genes--bookmaking, fortunetelling, and medical care. N Engl J Med. 1997 May 15;336(20):1448–1449. doi: 10.1056/NEJM199705153362009. [DOI] [PubMed] [Google Scholar]
  23. Hellman S. Karnofsky Memorial Lecture. Natural history of small breast cancers. J Clin Oncol. 1994 Oct;12(10):2229–2234. doi: 10.1200/JCO.1994.12.10.2229. [DOI] [PubMed] [Google Scholar]
  24. Hughes K. S., Roche C. A. How do we apply genetic testing for breast cancer susceptibility to clinical practice? J Surg Oncol. 1996 Jul;62(3):155–157. doi: 10.1002/(SICI)1096-9098(199607)62:3<155::AID-JSO1>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  25. Jonsen A. R., Durfy S. J., Burke W., Motulsky A. G. The advent of the "unpatients'. Nat Med. 1996 Jun;2(6):622–624. doi: 10.1038/nm0696-622. [DOI] [PubMed] [Google Scholar]
  26. KAISER R. F. Why cancer "control"? Public Health Rep. 1950 Sep 22;65(38):1203–1208. [PMC free article] [PubMed] [Google Scholar]
  27. KRAUS A. S. A review of the effectiveness of early treatment in breast cancer. Surg Gynecol Obstet. 1953 May;96(5):545–552. [PubMed] [Google Scholar]
  28. KREYBERG L. The significance of early diagnosis in breast cancer: a study of some common usages of the term. Br J Cancer. 1953 Jun;7(2):157–165. doi: 10.1038/bjc.1953.15. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Kahn P. Coming to grips with genes and risk. Science. 1996 Oct 25;274(5287):496–498. doi: 10.1126/science.274.5287.496. [DOI] [PubMed] [Google Scholar]
  30. Lerman C., Seay J., Balshem A., Audrain J. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 1995 Jul 3;57(3):385–392. doi: 10.1002/ajmg.1320570304. [DOI] [PubMed] [Google Scholar]
  31. Lerner B. H. Fighting the war on breast cancer: debates over early detection, 1945 to the present. Ann Intern Med. 1998 Jul 1;129(1):74–78. doi: 10.7326/0003-4819-129-1-199807010-00028. [DOI] [PubMed] [Google Scholar]
  32. Lewis D., Rienhoff W. F. Results of Operations at the Johns Hopkins Hospital for Cancer of the Breast: Performed at the Johns Hopkins Hospital from 1889 to 1931. Ann Surg. 1932 Mar;95(3):336–400. doi: 10.1097/00000658-193203000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lynch H. T., Krush A. J. Breast carcinoma and delay in treatment. Surg Gynecol Obstet. 1969 May;128(5):1027–1032. [PubMed] [Google Scholar]
  34. MACDONALD I. Biological predeterminism in human cancer. Surg Gynecol Obstet. 1951 Apr;92(4):443–452. [PubMed] [Google Scholar]
  35. MACDONALD I. The individual basis of biologic variability in cancer. Surg Gynecol Obstet. 1958 Feb;106(2):227–229. [PubMed] [Google Scholar]
  36. MCKINNON N. E. Limitations in diagnosis and treatment of breast and other cancers: a review. Can Med Assoc J. 1955 Oct 15;73(8):614–625. [PMC free article] [PubMed] [Google Scholar]
  37. MILLER M. W., PENDERGRASS E. P. Some observations concerned with carcinoma of the breast, part V. Pa Med J. 1954 May;57(5):421–425. [PubMed] [Google Scholar]
  38. Martensen R. L. Cancer: medical history and the framing of a disease. JAMA. 1994 Jun 22;271(24):1901–1901. [PubMed] [Google Scholar]
  39. McKINNON N. E. Control of cancer mortality. Lancet. 1954 Jan 30;266(6805):251–254. doi: 10.1016/s0140-6736(54)90892-2. [DOI] [PubMed] [Google Scholar]
  40. McKinnon W. C., Baty B. J., Bennett R. L., Magee M., Neufeld-Kaiser W. A., Peters K. F., Sawyer J. C., Schneider K. A. Predisposition genetic testing for late-onset disorders in adults. A position paper of the National Society of Genetic Counselors. JAMA. 1997 Oct 15;278(15):1217–1220. [PubMed] [Google Scholar]
  41. Modan B. The genetic passport. Am J Epidemiol. 1998 Mar 15;147(6):513–515. doi: 10.1093/oxfordjournals.aje.a009481. [DOI] [PubMed] [Google Scholar]
  42. PARK W. W., LEES J. C. The absolute curability of cancer of the breast. Surg Gynecol Obstet. 1951 Aug;93(2):129–152. [PubMed] [Google Scholar]
  43. Parens E. Glad and terrified: on the ethics of BRACA1 and 2 testing. Cancer Invest. 1996;14(4):405–411. doi: 10.3109/07357909609012169. [DOI] [PubMed] [Google Scholar]
  44. ROBBINS G. F., BERG J. W., BROSS I., DE PADUA C., SARMIENTO A. P. The significance of early treatment of breast cancer; changes correlated with the cancer education programs of 1940-1955. Cancer. 1959 Jul-Aug;12(4):688–692. doi: 10.1002/1097-0142(195907/08)12:4<688::aid-cncr2820120410>3.0.co;2-7. [DOI] [PubMed] [Google Scholar]
  45. ROBBINS G. F., BROSS I. The significance of delay in relation to prognosis of patients with primary operable breast cancer. Cancer. 1957 Mar-Apr;10(2):338–344. doi: 10.1002/1097-0142(195703/04)10:2<338::aid-cncr2820100214>3.0.co;2-i. [DOI] [PubMed] [Google Scholar]
  46. Reagan L. J. Engendering the dread disease: women, men, and cancer. Am J Public Health. 1997 Nov;87(11):1779–1787. doi: 10.2105/ajph.87.11.1779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Reiser S. J. The emergence of the concept of screening for disease. Milbank Mem Fund Q Health Soc. 1978 Fall;56(4):403–425. [PubMed] [Google Scholar]
  48. Retchin S. M., Wells J. A., Valleron A. J., Albrecht G. L. Health behavior changes in the United States, the United Kingdom, and France. J Gen Intern Med. 1992 Nov-Dec;7(6):615–622. doi: 10.1007/BF02599200. [DOI] [PubMed] [Google Scholar]
  49. Sackett D. L., Holland W. W. Controversy in the detection of disease. Lancet. 1975 Aug 23;2(7930):357–359. doi: 10.1016/s0140-6736(75)92790-7. [DOI] [PubMed] [Google Scholar]
  50. Schrag D., Kuntz K. M., Garber J. E., Weeks J. C. Decision analysis--effects of prophylactic mastectomy and oophorectomy on life expectancy among women with BRCA1 or BRCA2 mutations. N Engl J Med. 1997 May 15;336(20):1465–1471. doi: 10.1056/NEJM199705153362022. [DOI] [PubMed] [Google Scholar]
  51. Snyder R. E. Mammography and lobular carcinoma in situ. Surg Gynecol Obstet. 1966 Feb;122(2):255–260. [PubMed] [Google Scholar]
  52. Sox H. C. Benefit and harm associated with screening for breast cancer. N Engl J Med. 1998 Apr 16;338(16):1145–1146. doi: 10.1056/NEJM199804163381609. [DOI] [PubMed] [Google Scholar]
  53. Strax P. Strategy (motivation) for detection of early breast cancer. Cancer. 1980 Aug 15;46(4 Suppl):926–929. doi: 10.1002/1097-0142(19800815)46:4+<926::aid-cncr2820461312>3.0.co;2-3. [DOI] [PubMed] [Google Scholar]
  54. Struewing J. P., Lerman C., Kase R. G., Giambarresi T. R., Tucker M. A. Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families. Cancer Epidemiol Biomarkers Prev. 1995 Mar;4(2):169–173. [PubMed] [Google Scholar]
  55. TREVES N., HOLLEB A. I. A report of 549 cases of breast cancer in women 35 years of age or younger. Surg Gynecol Obstet. 1958 Sep;107(3):271–283. [PubMed] [Google Scholar]
  56. Tambor E. S., Rimer B. K., Strigo T. S. Genetic testing for breast cancer susceptibility: awareness and interest among women in the general population. Am J Med Genet. 1997 Jan 10;68(1):43–49. [PubMed] [Google Scholar]
  57. URBAN J. A. Early diagnosis of breast cancer; salvage data with lesions considered clinically benign or doubtful prior to operation. Cancer. 1956 Nov-Dec;9(6):1173–1176. doi: 10.1002/1097-0142(195611/12)9:6<1173::aid-cncr2820090618>3.0.co;2-o. [DOI] [PubMed] [Google Scholar]
  58. Von Kleist S. Prognostic factors in breast cancer: theoretical and clinical aspects (review). Anticancer Res. 1996 Nov-Dec;16(6C):3907–3912. [PubMed] [Google Scholar]
  59. Welch H. G., Burke W. Uncertainties in genetic testing for chronic disease. JAMA. 1998 Nov 4;280(17):1525–1527. doi: 10.1001/jama.280.17.1525. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Public Health are provided here courtesy of American Public Health Association

RESOURCES